YFY Biotech Management Company
Venture capitalTaipei · Seed–Series B · 1 people tracked
Find your way into YFY Biotech Management Company
Investment thesis
The firm operates as a biotech incubator, investment and management-advisory team created by Taiwan's YFY Group. Established in 2003, it raised the Sun Way Biotech venture capital fund in 2005. Its advisory team brings cross-disciplinary experience spanning industry, government, academia, research and investment, with expertise in biomedical technology, intellectual-property management, policy and regulatory affairs, operations, finance and capital raising. It supports biotech companies through incubation, investment and hands-on management guidance.
Source: firm website, verified Aug 17, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
HQs:Taiwan×1
Investments · 2 tracked
founders shown can be your intro pathTaiMed Biologics is a Taiwan-based biopharmaceutical company that develops monoclonal antibody therapies for HIV, including the long-acting TMB-365/TMB-380 combination and the CD4-targeted ADC platform extending into autoimmune diseases.
BiotechHealthtechMedical Devices
Jimmy Chang(CEO)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
太景
Frequently asked questions
- What stage does YFY Biotech Management Company invest at?
- YFY Biotech Management Company invests at the Seed, Series A, Series B stages.
- What sectors does YFY Biotech Management Company focus on?
- YFY Biotech Management Company focuses on Biotech, Healthtech, Medical Devices.
- Where is YFY Biotech Management Company located?
- YFY Biotech Management Company is headquartered in Taipei, TW.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.



.jpeg)
